News Website

Endometrial Cancer: Toxicity Management and Treatment Persistence with Lenvatinib-Pembrolizumab - OncLive

Endometrial Cancer: Toxicity Management and Treatment Persistence with Lenvatinib-Pembrolizumab OncLive

Published: Dec. 26, 2025, 1:19 p.m.

Read Full Article

Endometrial Cancer: Counseling on dMMR vs pMMR - Explaining Survival Advantage and Clinical Expectations - OncLive

Endometrial Cancer: Counseling on dMMR vs pMMR - Explaining Survival Advantage and Clinical Expectations OncLive

Published: Dec. 26, 2025, 1:19 p.m.

Read Full Article

In Situ Characterization and Deep Profiling of Engineered Multispecific Nanoparticle Metabolite Coronas for Precise Serum Diagnostics.

Upon exposure to biofluids, engineered nanoparticles (NPs) spontaneously form reproducible biomolecular coronas via selective diverse biomolecule adsorption. The corona characterization of metabolites poses greater analytical challenges than proteins due to …

Published: Dec. 26, 2025, midnight

Read Full Article

After comparing endometrial cancer minimally invasive surgery, laparotomy, survival rate and complications... - MSN

After comparing endometrial cancer minimally invasive surgery, laparotomy, survival rate and complications... MSN

Published: Dec. 25, 2025, 7:50 p.m.

Read Full Article

Predictive value of MR imaging IVIM and T2 mapping in malignant transformation of endometriosis.

This study aims to explore the value of MRI intravoxel incoherent motion (IVIM) combined with T2 mapping in predicting the malignancy of endometriosis (EM) and construct a noninvasive preoperative risk …

Published: Dec. 24, 2025, midnight

Read Full Article

T2 mapping endometriosis intravoxel incoherent motion magnetic resonance imaging malignant transformation

Study Explores Cancer-Like Traits in Endometriosis Including Abnormal Cell Growth and Tissue Invasion - geneonline.com

Study Explores Cancer-Like Traits in Endometriosis Including Abnormal Cell Growth and Tissue Invasion geneonline.com

Published: Dec. 23, 2025, 8:37 p.m.

Read Full Article

Endometriosis: Unveiling Its Cancer Hallmarks - BIOENGINEER.ORG

Endometriosis: Unveiling Its Cancer Hallmarks BIOENGINEER.ORG

Published: Dec. 23, 2025, 8:14 p.m.

Read Full Article

Endometriosis: Unveiling Its Cancer Hallmarks - Bioengineer.org

Endometriosis: Unveiling Its Cancer Hallmarks Bioengineer.org

Published: Dec. 23, 2025, 8:14 p.m.

Read Full Article

Phase 3 Trial of T-DXd Initiated in HER2+ Endometrial Cancer - Targeted Oncology

Phase 3 Trial of T-DXd Initiated in HER2+ Endometrial Cancer Targeted Oncology

Published: Dec. 23, 2025, 2:07 p.m.

Read Full Article

First patient dosed in phase 3 trial evaluating ENHERTU in endometrial cancer - Investing.com Nigeria

First patient dosed in phase 3 trial evaluating ENHERTU in endometrial cancer Investing.com Nigeria

Published: Dec. 23, 2025, 2:36 a.m.

Read Full Article

Latest Articles

Endometrial Cancer: Toxicity Management and Treatment Persistence with Lenvatinib-Pembrolizumab - OncLive

Endometrial Cancer: Counseling on dMMR vs pMMR - Explaining Survival Advantage and Clinical Expectations - OncLive

In Situ Characterization and Deep Profiling of Engineered Multispecific Nanoparticle Metabolite Coronas for Precise Serum Diagnostics.

After comparing endometrial cancer minimally invasive surgery, laparotomy, survival rate and complications... - MSN

Predictive value of MR imaging IVIM and T2 mapping in malignant transformation of endometriosis.

Study Explores Cancer-Like Traits in Endometriosis Including Abnormal Cell Growth and Tissue Invasion - geneonline.com

Endometriosis: Unveiling Its Cancer Hallmarks - BIOENGINEER.ORG

Endometriosis: Unveiling Its Cancer Hallmarks - Bioengineer.org

Phase 3 Trial of T-DXd Initiated in HER2+ Endometrial Cancer - Targeted Oncology

First patient dosed in phase 3 trial evaluating ENHERTU in endometrial cancer - Investing.com Nigeria

Subscribe to Our Newsletter